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Open access under CC BY license.P2X receptors are ATP-gated membrane ion channels
with multifarious roles, including afferent sensation,
autocrine feedback loops, and inflammation. Their mol-
ecular operation has been less well elucidated compared
with other ligand-gated channels (nicotinic acetyl-
choline receptors, ionotropic glutamate receptors). This
will change with the recent publication of the crystal
structure of a closed P2X receptor. Here we re-interpret
results from 15 years of experiments using site-directed
mutagenesis with a model based on the new structure.
Previous predictions of receptor stoichiometry, the
extracellular ATP binding site, inter-subunit contacts,
and many details of the permeation pathway fall into
place in three dimensions. We can therefore quickly
understand how the channel operates at the molecular
level. This is important not only for ion- channel aficio-
nados, but also those engaged in developing effective
antagonists at P2X receptors for potential therapeutic
use.
Introduction
Like many other transmitters, extracellular nucleotides
act on two types of cell membrane receptor. These are ion
channels (termed ‘P2X’) and G protein-coupled (termed
‘P2Y’) receptors [1]. P2X receptors first came to prominence
as the ligand-gated ion channels involved in transmission
from sympathetic nerves to smooth muscle effectors [2],
just as nicotinic acetylcholine receptors were discovered by
their role in somatic neuromuscular transmission [3], and
glutamate receptors for their analogous function in the
central nervous system [4]. It is now clear that for P2X
receptors this fast signalling represents only one end of a
broad functional spectrum. It is also apparent that in most
tissues nucleotides act as paracrine transmitters that dif-
fuse considerable distances and act over several seconds
rather than a few milliseconds. Over the past decades,
interpretation of the functional roles of P2X receptors has
beenhandicappedbya lackof specificpharmacological tools.
It has been further complicated by the discovery that some
P2X receptors (notably P2X7) do not simply open a narrow
conducting pathway to allow the passage of small ions, but
also become progressively permeable to larger cations such
as N-methyl-D-glucamine and propidium dyes [5].
P2X receptors are widely distributed in mammalian
tissues. Seven subunits are encoded in mammalian gen-
omes, and these form channels as homotrimers or, in a few
circumstances, as heterotrimers (e.g. P2X2 and P2X3,Corresponding author: North, R.A. (r.a.north@manchester.ac.uk)
0165-6147 2010 Elsevier Ltd. All rights reserved. doi:10.1016/j.tips.2010.02.004P2X1 and P2X5) [6]. They fulfil roles that extend from
thrombosis through gastrointestinal motility, afferent sen-
sation (including chemoreception and taste), renal auto-
regulation and bone resorption, to inflammation [6–8]
(Table 1). Such roles have now been firmly validated by
studies in mice in which one or more of the subunits has
been genetically eliminated. Accordingly, exploitation of
these potential new therapeutic targets has focused on
P2X1 receptors for disorders of the urinary tract; P2X3
and the heteromeric P2X2/3 receptors in pain; P2X4 recep-
tors in neuropathic pain; and P2X7 receptors for blocking
the release of inflammatory cytokines [9] (Table 1).
cDNA cloning of P2X receptors in the mid-1990 s led to
the deduction of a receptor structure that was very differ-
ent from the ligand-gated ion channels then known (i.e.
nicotinic receptors [including receptors for g-aminobutyric
acid, glycine and 5-hydroxytryptamine], and glutamate-
gated channels). Each subunit had two membrane-span-
ning domains (TM1 and TM2), and the N-termini and C-
termini were within the cell: the bulk of the receptor
protein was extracellular (280 amino acids: the ‘ectodo-
main’; Figure 1a). In general terms, this resembles the
topology of the epithelial sodium channel (ENaC) and its
relatives in Caenorhabditis elegans (mechano-sensitive
channels, the degenerins). However, except for the acid-
sensing ion channels (ASIC), those channels are not
usually considered to be ligand-gated [14].
The functional expression of these cDNAs has enabled a
determined effort to deduce the molecularmodus operandi
of P2X receptors. There have been many studies using
mutagenesis combined with functional expression, some
showing considerable ingenuity. Taken together, these
have allowed the initial designation of certain amino acids
residues as being involved in specific functional aspects
(e.g. ATP binding, ion permeation). The purpose of this
review is to re-interpret such work in the context of the 3.5-
A˚ structure of the zebrafish P2X4 receptor recently solved
by Gouaux and colleagues [10]. This will assist under-
standing of the molecular detail of channel function, and
provide a basis for the design and study of pharmacological
agents. We have generated a model of the rat P2X2 re-
ceptor, which has been the principal subject of structure–
function studies; residues identified in this article are
numbered accordingly.
How many subunits make a P2X receptor?
The careful work of Bean [15] on the initial slope of ATP
dose–response curves prompted suggestions that P2XAvailable online 11 March 2010 229
Table 1. Summary of the major physiological functions of P2X receptors
Receptors Functions
P2X1 Contraction of the vas deferens and male fertility [64], renal microvascular autoregulation [65], thrombosis [66],
and neutrophil chemotaxis [67]
P2X2, P2X3 or P2X2/3 Inflammatory and neuropathic pain [68–70], urinary bladder reflex [68], enteric neurotransmission and
peristalsis [71,72], chemoreception [73,74], and taste transduction [75]
P2X4 Neuropathic pain [76], long-term potentiation in the hippocampus [77], and vascular tone and remodelling [78]
P2X7 Cytokine release [79], bone remodelling [80], inflammatory and neuropathic pain [81,82], collagen deposition
and renal fibrosis [83], and glia–neuron interactions [84,85]
Review Trends in Pharmacological Sciences Vol.31 No.5receptors open in response to the binding of three agonist
molecules. Consistent with this, the availability of
expressed proteins showed that the receptor was a trimer
activated by three molecules of ATP (blue native polyacryl-
amide gel electrophoresis [16] and functional studies using
Hill plots [17] or concatenated subunits [18]). Purified
receptors observed by atomic force microscopy [19] and
electron microscopy [20] also showed threefold symmetry.
The imagination of Oregon scientists [10] shows each of
these three subunits as a dolphin rising from the surface of
the ocean (cell membrane), with its tail submerged within
the lipid bilayer (Figure 1b). The body regions of three such
‘dolphins’ mutually intertwine so as to surround a central
vertical cavity (Figure 1a). The arching body of the dolphin
allows the head/beak region to position more horizontally,
lying across and making contact with the body of a
neighbouring subunit. In the head and beak region are
found three of the disulfide bridges previously predicted
on the basis of mutagenesis (Cys113–Cys164, Cys124–Cys147,
Cys130–Cys158) [21,22] (Figure 1c), whereas the
Cys214–Cys224 disulfide is located within the dorsal fin.
The Cys258–Cys267 disulfide bridge joins the ends of
two b-strands low in the body region (Figure 1c). These
disulfides bridges are not essential to P2X receptor function
because most are not present in a Dictyostelium receptor
(DdP2XA), which also forms an ATP-gated channel [23].
The three subunits have several regions of contact, some
of which have been demonstrated through mutagenesis by
the formation of ‘ectopic’ disulfide bonds. Thus, a disulfide
bond is formed when cysteines are introduced at the pos-Figure 1. Three subunits form one P2X receptor. (a) The trimeric rat P2X2 model, viewed
depicted in a different colour. (b) A single P2X2 subunit, viewed parallel to the membran
five disulfide bonds within a single P2X2 subunit. Sulfur atoms are shown in grey. (d)
pocket which they jointly form. This and subsequent figures show homology models of
crystal structure (PDB accession 3I5D) as a template. MolProbity [12] was used to assess
allowed regions of the Ramachandran plot. Images were produced using UCSF Chime
230itions normally occupied by His120 and His213: these his-
tidines mediate binding and facilitation of P2X2 receptor
currents by zinc [24] (Figure 1d). Hume and colleagues
used concatenated subunits to show that these zinc-bind-
ing histidines are provided by different subunits [24] and
put forward evidence that these as well as additional
residues were probably close to the ATP-binding site
[25] (Figure 1d).
A second ectopic disulfide bond that has been reported is
between cysteines introduced at the positions of Lys69 and
Phe289 [26] (first shown for Lys68 and Phe291 in the rat
P2X1 receptor [27]) (Figure 2). A third locus of inter-sub-
unit contacts has also been demonstrated by formation of a
disulfide bond between cysteines substituted for residues
Val48 and Ile328 [28] located at the outer ends of TM1 and
TM2, and channel opening occurs only when this disulfide
bond is reduced [17,28]. An additional inter-subunit con-
tact that has not been tested by mutagenesis is located
between the short helix in the dorsal fin of one subunit and
an exposed loop in the left flipper of another. The broad
concordance with previous mutagenesis studies provides
compelling evidence that the channel crystallised by
Kawate et al. [10] corresponds to the closed state of a
functional trimer that has been extensively studied in
expression systems over the past 15 years.
Where does ATP bind?
The structure solved by Kawate et al. [10] was in the
absence of ATP, so we can not see directly where
the agonist binds. P2X receptors do not exhibit any of thealong the axis of threefold symmetry from the extracellular side, with each subunit
e plane with the outline dolphin suggested by Kawate et al. [10]. (c) Depiction of the
Two subunits of the P2X2 receptor presented so as to emphasise the ATP binding
the rat P2X2 receptor generated with Modeller 9v7 [11] using the zebrafish P2X4.1
the five lowest-energy models: the selected model showed 98.9% of residues in the
ra 1.4 [13].
Figure 2. The ATP-binding site. (a) and (b) Space-fill models at 908 to each other viewed parallel to the membrane plane showing the binding pocket for ATP formed
between adjacent subunits (shown in blue and yellow). Eight highly conserved residues positioned within the ATP binding pocket are indicated, with the respective ribbon
diagrams shown in (c) and (d). We speculate that the negatively charged phosphate groups may interact with the positively charged Lys69 and Lys308 residues, whereas
Arg290 may interact with the adenine moiety. The ATP molecule (ligand from PDB accession 1B0U) is coloured by element. The amino acid side chains are colour-coded by
property as follows: positively charged (green), aromatic (red) and hydrophobic (purple).
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binding sites in large numbers of intracellular proteins
such as kinases. Conversely, a comparison of sequences
that are distantly related through phylogeny (e.g. algae,
slime mould amoebae, choanoflagellates [8]) but which are
known to form functional channels shows that relatively
few of the 280 residues of the extracellular domain are
strongly conserved across all receptors (notably Lys53,
Tyr55, Lys69, Lys71, Asp82, Gln108, Asn182, Phe183, Thr184,
Leu260, Asp261, Asn288, Phe289, Arg290, Arg304, Leu306,
Lys308, Tyr310, Gly311, Arg313, Gly320 and Phe325). Many of
these residues have been suggested to be involved in ATP
binding from functional studies.
The model structure places most of these conserved
residues within or adjacent to a pocket formed between
the body region of two subunits (Figure 2). Eight residues
are most closely involved, four from each of two different
subunits (Lys69, Lys71, Phe183 andThr184 from one subunit,
and Asn288, Phe289, Arg290 and Lys308 from another). Of
these, two (Lys69 and Phe289) are sufficiently proximal to
form a disulfide bridge when they are replaced by cysteine,
and under oxidising conditions such a channel migrates as
a trimer [26,27] (trimer formation is prevented if ATP is
present, which was also consistent with these residues
forming part of the binding pocket). A contribution to
the ATP binding pocket by Lys69 and Lys308 from different
subunits was first proposed by Wilkinson et al. [29], and
this is now obvious in the model structure (Figure 2).
Substitutions at these eight positions in P2X2 and the
equivalent residues in other P2X receptors has previously
been shown to inhibit strongly or prevent completely the
action of ATP to open the channel (Table 2).Jiang et al. [30] studied the effects of substitution at Ile67.
They found that replacement with a positively charged
residue (I67R, I67K, or I67C followedbyapositively charged
methanethiosulfonate (MTS)) reduced themaximal effect of
ATPwithout changing the sensitivity (measuredas theATP
concentration giving half the maximal current (EC50)).
Introduction of a negative charge (I67E, I67D, or I67C
followed by a negatively charged MTS) caused a parallel
rightward shift in the ATP concentration–response curves.
In pharmacological parlance, this latter inhibition was ‘sur-
mountable’. It was deduced that Ile67 was very close to the
ATP-binding site, and that the microscopic affinity for ATP
was reducedby electrostatic repulsion.Consistentwith this,
the reaction of I67C with a negatively charged MTS was
prevented if ATP was first applied. In the structural model,
Ile67 is positioned at the lower lip of the ATP binding jaw,
providing a good explanation for the conclusions of Jiang
et al. [30] (Figure 2).
Ectodomain binding of receptor antagonists
Models of mammalian P2X receptors based on the struc-
ture of the zebrafish receptor make clear what had been
long suspected: the ectodomain presents a highly variable
surface to the aqueous environment. Ectodomain
sequences of the seven mammalian receptors range in
pairwise identity from about 40% to 50%, which should
provide reasonable scope for development of selective
drugs. This goal has been achieved in several cases, but
in only a few is there any clue as to the structural basis of
selectivity. Suramin is one of the first P2X receptor
antagonists. Suramin and its analogue NF449 appear to
owemuch of their high potency at the humanP2X1 receptor231
Table 2. ATP-binding residues. For eight residues positioned at the ATP-binding pocket, substitutions reduce the effectiveness of
ATP to open the P2X receptor channel expressed in heterologous cells. D indicates the log10 of the change in concentration of ATP
causing half-maximal current (EC50), >4 indicates <10% of wild-type current even at 3–10 mM ATP, 300 mM BzATP or abmeATP.
aP2X3 receptors tested with abmeATP.
P2X1 D P2X2 D P2X3a D P2X4 D P2X7 D References
K68A 3.2 K69A >4 K63A >4 K67A >4 K64A >4 29,30,86,87,88,89
K68R >4 K69C >4 K67C >4
K69R 2.5 K67R >4
K70A 0.7 K71A 2.7 K65A 1.1 K69C >2.4 30,86,87,88
K70R 1.3 K71C 3.0
K71R 0.6
F185A 1.0 F183C 0.5 F185A 1.0 87,89,90,91
F185C 0.3 F185C 1.3
F185W 0.3
T186A 0.8 T184A 2.1 T186C 1.7 30,87,91,92
T186C 0.9 T184C 1.0
N290A 1.8 N288A 2.0 N293C >2.4 30,87,92,93
N290C 1.9 N288C >2.4
F291A 2.2 F289C 0.7 F294A 0.9 87,89,90,93
F291C 1.7 F294W 0.6
R292A 2.0 R290A 2.4 R281A >1.8 R295A >3 30,86,87,88,89,93
R292C 1.3 R290C >2.4 R295K >3
R292K 2.1 R290K 0.9
K309A 3.2 K308A >4 K299A >4 K313A >3 30,86,88,93,94,95,96
K309C 2.3 K308C >4 K313R >3
K309R 1.4 K308R 1.5
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(Asp136 in rat P2X2) [31]. This lysine is positioned in a short
helix that forms the lowerpart of thedolphin’sbeak, forming
the upper lip of the ATP-binding jaw.
Most P2X receptors are blocked by pyridoxalphosphate-
6-azophenyl-2’,4’-disulfonic acid (PPADS) but, when it was
first cloned, the rat P2X4 receptor was found to be rela-
tively insensitive [32]. A straightforward exchange of one
lysine residue found in the PPADS-sensitive P2X2 receptor
(Lys246) to the equivalent position in the P2X4 receptor
(Glu249) transferred the PPADS sensitivity. Conversely,
the substitution K246E in P2X2 converted the block by
PPADS from essentially irreversible to quickly reversible.
These results suggested that lysine at this position might
form a Schiff base with the aldehyde moiety of PPADS,
thereby preventing access of ATP to the receptor. The P2X2
receptor model places this lysine side chain extending in
from the side of the mouth of the ATP binding jaw.
Michel et al. [33] showed that Phe95 in human P2X7
was required for high sensitivity to antagonists/allosteric
modulators, including GW791343 (2-[(3,4-difluorophenyl)
amino]-N-[2-methyl-5-(1-piperazinylmethyl)phenyl]-aceta-
mide), SB203580 (4-[5-(4-fluorophenyl)-2-[4-(methylsulfo-
nyl)phenyl]-1H-imidazol-4-yl]pyridine) and KN-62. The
equivalent residue (Ile94 in zebrafish P2X4; Lys88 in rat
P2X2) is found adjacent to a highly conserved proline deep
inside theATPbinding cavity,whereanattachedantagonist
might readily impede agonist binding. Determining the
residues involved in the binding of the ever-increasing
number of P2X receptor antagonists [9,33], and designing
new selective antagonists de novo using in silico methods
will be very important.
How do ions permeate the channel?
Two main approaches, each combined with site-directed
mutagenesis, have been used to identify the key regions232involved in ion permeation. First, there are estimates
of the relative calcium permeability of the channel (e.g.
PCa/PCs ratios or, more informatively, the fraction of the
inward current carried by calcium (Pf%)). Second, the
effects of applying MTSs on the ATP-evoked currents have
been studied on channels in which a single amino acid has
been replaced by cysteine.
TM1 residues
The first approach suggests that TM1 residues (Figure 3a)
are not significantly involved in determining the relative
calcium permeability of the P2X2 receptor [34], but there
are two caveats to this approach. The first relates to Gln52
(of the rat P2X2 receptor). This residue is Glu in P2X1 and
P2X4 receptors, and mutagenesis shows that in these
receptors it is at least partially responsible for the high
Pf% [35]. The conclusion that the negative charge of this
Glu helps to concentrate calcium ions in the extracellular
vestibule is well borne out by the structure. The second
caveat pertains to Tyr43, which is conserved among all P2X
receptors: removal of the Tyr at this position altered Pf%
and PCa/PCs, but probably by an indirect mechanism rather
than by contacting permeating ions [34]. In the model
structure, this residue is well away from the permeation
pathway. However, this central region of TM1 is at the
closest point of interaction between the two crossing TM
helices, and Phe44 and Ile40 from TM1 probably make
hydrophobic interactions with Leu334 and Ile341 in TM2.
The substitution F44C increases sensitivity to ATP [28],
perhaps by facilitating inter-helix rearrangements during
opening.
The second approach, the substituted cysteine accessi-
bility method, also provided little consistent evidence that
TM1 residues were exposed to the aqueous permeation
pathway [28,36,37]. However, these results showed that
Val48 (at the outer end of TM1) moves during channel
Figure 3. The transmembrane domains. (a) TM1 viewed parallel to the membrane with side chains coloured by element. (b) The close proximity of Val48 and Ile328 (purple)
of TM1 and TM2 from different subunits, viewed perpendicular to the membrane plane from the extracellular side. (c) TM2 with side chains shown with standard element
colours. (d) The narrowest part of the pore with polar gating residues Thr336, Thr339 and Ser340 indicated (light blue).
Review Trends in Pharmacological Sciences Vol.31 No.5opening so as to become more accessible to polar MTS
compounds [28]. As mentioned above, a cysteine intro-
duced at this position can disulfide bond with a cysteine
at position Ile328 on an adjacent subunit (Figure 3b) and
this disulfide bond inhibits channel opening [17,28].
TM2 residues
The two approaches together have profoundly implicated
TM2 (Figure 3c) in the aqueous permeation pathway.
Thus, the relatively higher Pf% of P2X1 and P2X4 recep-
tors appears to result (at least in part) from the acidic side
chains provided by Asp in the outer vestibule [35] (this
residue is Ser326 in the P2X2 receptor). Deeper within
TM2, measurements of relative calcium permeability
[38] and Pf% [39] clearly identify Thr336, Thr339 and
Ser340 as providing side chains that interact with permeat-
ing calcium ions. The substituted cysteine accessibility
method using MTS compounds and silver also place the
same residues in the narrowest part of the permeation
pathway [37,40,41]. The most recent studies show that the
rates of modification of T336C and T339C (in rat P2X2) by
2-(trimethylammonium)ethyl-MTS (MTSET) are >1000-
times faster when the channel is open than when the
channel is closed [37], suggesting that the ‘gate’ is external
to T336. Conversely, when cadmium is used as the probe,
the gate lies between T336 and T339 [42]. Cadmiumhas an
ionic radius similar to that of sodium, whereas MTSET is
substantially larger. Themodel structure provides a plaus-
ible explanation for this because the side chains of Thr336
and Thr339 would be barely accessible in the closed channel(Figure 3d), even though they become accessible during
opening. Given the differences in TM2 residues among
species in this region (the corresponding residues are
Ala344 and Ala347 in the zebrafish P2X4 receptor), further
direct structural informationwill be required to resolve the
side-chain orientations of TM2 residues in the open and
closed states.
Three further approaches have been applied recently to
the study of TM2: (i) appearance of spontaneous gating, (ii)
changes in the unitary conductance, and (iii) alterations in
open channel rectification resulting from the introduction
of positive charges [43]. Almost any substitution intro-
duced at Thr336 (including cysteine) results in P2X2 chan-
nels that are spontaneously active in the absence of applied
ATP, suggesting thatmovements of this residue are critical
to channel opening. At Thr339, only two such substitutions
provided spontaneous activity (T339S and T339G) and a
range of other side chains were tolerated. The introduction
of a positively charged side chain, or cysteine followed by a
positively charged MTS, at Thr336 or Thr339 also markedly
changed the rectification normally exhibited by P2X re-
ceptor currents. Outward currents were strikingly
increased, implying an altered interaction with permeat-
ing ions. Thr336 and Thr339 are found on the same face of
the TM2 helix (Figure 3c), and form the narrowest part of
the closed channel in the P2X2 model (Figure 3d).
Studies on Ser340 have been handicapped by the finding
that the mutation S340C produces channels that do not
respond to ATP [37,41] or respondwith small currents [40].
However, Cao et al. [43] reported that channels with a233
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edly increased outward currents, and this could be
mimicked in S340C by applying the positively charged
MTSET. This observation indicates that the side chain
at this position is also exposed in the permeation pathway,
as initially suggested by Migita et al. [38] on the basis of
their measurements of PCa/PCs. In the closed structure of
the P2X receptor provided by Kawate et al. [10], the side
chain of Ser340 (Leu348 in zebrafish P2X4 receptor) is
pointing away from the central axis of symmetry
(Figure 3c,d), which is presumed to form the open per-
meation pathway.
Channel opening
The side chains of Thr336, Thr339 and Ser340 influence the
movement of permeant ions (rectification, MTSET acces-
sibility) [43]. This implies that the closed to open move-
ment involves a counter-clockwise rotation by 508. This
would break the close apposition between Val48 and Ile328
of the neighbouring subunit mentioned above (Figure 3b).
It would swing out of the way the hydrophobic side chain of
Ile332 (equivalent to Leu340 in the zebrafish P2X4 receptor
[10]) that appears to close the channel from the extracellu-
lar aspect (Figure 3c). This suggestion is compatible with
the prediction of Silberberg et al. [44] that a rotation and
splaying of the helices during opening could best explain
the potentiating action of ivermectin at P2X4 receptors.
The observation that the side chains of Thr336, Thr339 and
Ser340 from each of the three subunits are exposed to
permeating ions [43] suggests that TM2 helices not only
rotate as the channel opens, but also become more steepFigure 4. The connecting rods and a possible opening mechanism. (a) A single subunit v
sheets) each rising from the TM1 or TM2 helices. (b) Two connecting rods from two di
within the ATP binding pocket (including the critically implicated Lys69 and Lys308 residue
the rigidity within each connecting rod compared with the limited contacts between adja
been omitted for clarity. (c) This highly schematic cartoon shows a possible mechanis
Lys308 relative to Lys69, and the connecting rod propagates a rotating and separating m
234from the relatively oblique angle (458) at which they cross
the membrane in the closed state [10]. Channel opening
must also be associated with substantial movements of the
inner part of the TM2 helices, which are splayed out in the
closed state model (Figure 3), because MTSEA [40,41] and
cadmium [42] block currents at rat P2X2 receptors that
incorporate D349C. The irreversible coordination of cad-
mium by that receptor [42] clearly implies helical steepen-
ing, or perhaps bending at Gly344 [45], during opening.
Structures of open and desensitized states are required.
The permeation pathway of P2X receptors undergoes a
progressive dilation when the agonist application is main-
tained. This is most directly observed as a progressive
increase in permeability to N-methyl-D-glucamine
(NMDG) over several seconds [5,46–49]. NMDG is a mono-
valent cation that is too large (molecular weight, 196) to
permeate the calcium/sodium/potassium-selective channel
that opens when ATP is first applied. The slowly develop-
ing current (I2: seconds) can also be distinguished from the
rapid current (I1: milliseconds) on kinetic grounds [46].
Khakh et al. [46] have shown that, in the case of the P2X4
receptor, point substitutions at position Gly347 (Gly342 in
rat P2X2) alter the relative amplitude of I1 and I2; replace-
ment with Tyr eliminates I2 but not I1, whereas substi-
tution with Lys or Arg at this position selectively reduces
the I1 component. They suggested that moving interfaces
between the subunits may allow the progression from the
I1 to the I2 state [50].
It is becoming increasingly clear from studying other ion
channels (e.g. mechano-sensitive channels) that very large
increases in size of the permeation pathway can resultiewed parallel to the membrane plane, with two connecting rods (the linkers and b-
fferent subunits, which contribute almost all of the eight highly conserved regions
s). In (a) and (b) the backbone hydrogen bonds are shown (light blue) to emphasise
cent connecting rods. Loops and helices that do not form the connecting rods have
m for connecting ATP binding to channel gating. ATP binding (lower) repositions
ovement to TM2 relative to TM1.
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structural model provides a firm basis on which to test the
hypothesis that pore dilation results from progressive
rotation and separation of the helix so as to open a larger
permeation pathway. The first ‘shutter-stop’ of the three-
helix iris might be a narrow channel selective to small
cations; a second ‘shutter-stop’ might provide a channel
that is also permeable to larger cations.
Connecting binding to gating
The predicted ATP-binding site is 40 A˚ from the outer
surface of the membrane bilayer. The two lysine residues
most critically implicated in binding to ATP (Lys69 and
Lys308, see above) are each about 20 amino acids removed
from the outer end of TM1 (at Val51) and the outer end of
TM2 (at Leu327). In each case, the structure linking the
ATP-binding jaw to the outer end of the TM helix is a two-
or three-stranded b-sheet, with a short linker at the mem-
brane proximal portion; these are termed ‘connecting rods’
(Figure 4).
Within a single subunit, each connecting rod is rela-
tively rigid due to backbone hydrogen bonding between b-
strands (Figures 4a and b). There is also probably a hydro-
gen bond between the side chains of Tyr55 and Asp261 (two
of the most highly conserved residues among the entire
P2X receptor family). Tyr55 is at the linker extracellular of
TM1, whereas Asp261 is located on a loop at the membrane
proximal end of the TM2 connecting rod; mutation of either
of these residues leads to complete loss of receptor function
[28,40]. The strands also make contact in this region by a
disulfide bond between Cys258 and Cys267 (Figure 1c). The
model indicates minimal interaction between each con-
necting rod (Figure 4b), suggesting that they are free to
move as they transmit the opening force from binding site
to transmembrane helices, rotating and separating them
as the pore opens (Figure 4c).
Lessons for a broader channel family
Fifteen years ago, degenerins came to our attention
because a mutant Caenorhabditis elegans was insensitive
to gentle touch. This proved to result from a point mutation
(Ala673 in Mec-10; Ala442 in Mec-4) that led to spontaneous
activity of a mechano-sensitive channel, and consequent
death of the few neurons that express the channel [53,54].
Epithelial sodium channels were discovered in the search
for the molecular basis of high blood pressure (particularly
Liddle’s syndrome) [55]. Interest in the molecular identity
of P2X receptors was driven largely by studies of chemical
transmission in the autonomic nervous system [56–58].
These disparate physiological approaches have been
brought together by the recent structural work from
Gouaux and colleagues [10], which clearly shows that
P2X receptors are related to the degenerin/ENaC/ASIC
family of ion channels [59,60]. This was not obvious from
amino acid sequence alignments, and was further thought
to be unlikely on the basis of spurious assignments of
receptor stoichiometry in the case of degenerins/ENaC/
ASIC (see [61]). Thus, discordant avenues of physiological
investigation that were quite divergent in 1994 are now
moving together. Not only has the ‘P2X prodigal child’
returned, but a family who hardly knew each other hasbeen reunited. It is fully to be expected that they will spend
the next period getting to know each other, and thus
elucidating their common features of molecular operation.
Concluding remarks
Current interpretation of the functional properties of P2X
receptors in terms of atomic structure will presage a much
more detailed understanding of how ligands bind to these
receptors. Determining the structure of the open channel,
the channel boundwith ATP, and even the dilated channel,
will be important. Structure-based drug design and com-
putational methods can now be used to address the paucity
of small molecule pharmacological tools that has handi-
capped progress towards a fuller understanding of func-
tion. The differences in structure among the seven
mammalian P2X receptor subunits can be used to develop
subunit specific antagonists. We must hope that some of
these tools can be developed into new therapeutics,
particularly in neuropathic pain and inflammation [62,63].
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